ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1650296
This article is part of the Research TopicThe Gut-Brain Axis: Microbiota-Driven Immune Modulation and its Impact on Neurological HealthView all 9 articles
Multi-Omics Analysis Reveals Angelica dahurica Radix Extract Alleviates Migraine in Rats via Gut Microbiota-Metabolome-Gut-Brain Axis Regulation
Provisionally accepted- 1Chengdu University of Traditional Chinese Medicine School of Pharmacy, Chengdu, China
- 2Chengdu University of Traditional Chinese Medicine, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Emerging evidence links gut-brain axis dysregulation to migraine pathogenesis. Angelica dahurica Radix (Baizhi) demonstrates clinical efficacy in migraine management, yet its mechanisms involving gut microbiota-metabolite crosstalk remain unelucidated. Methods: A nitroglycerin (NTG)-induced migraine rat model was established. Migraine behaviors were video-recorded. Enzyme-linked immunosorbent assay (ELISA) was used to quantify neuroinflammatory and neurotransmitter markers (5-HT, CGRP1, TNF-α, NO, PGE2, DA) in plasma and brain tissue.. Intestinal barrier integrity was evaluated by immunohistochemical staining of tight junction proteins (Occludin/ZO-1) and hematoxylin-eosin (H&E) staining of colonic tissue. Gut microbiota composition was analyzed via 16S rRNA gene sequencing of fecal samples, and serum metabolomic profiles were characterized using ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF MS). Multi-omics data were integrated to identify key therapeutic targets and pathways. Results: Baizhi alleviated migraine behaviors (head-scratching frequency reduced) and normalized neurochemical dysregulation (plasma and brain tissue 5-HT, CGRP1, TNF-α reduced vs. model). It restored intestinal barrier integrity via Occludin/ZO-1 upregulation and suppressed colonic inflammation. Gut microbiota analysis demonstrated that Baizhi increased the abundance of Firmicutes and beneficial genera, such as Lactobacillus and Ruminococcus_gnavus_group, while decreasing Bacteroidetes. Gut microbiota remodeling correlated with F/B ratio elevation and Lactobacillus enrichment. Key regulated pathways included tryptophan metabolism (5-HT synthesis) and mitochondrial-associated arginine-proline metabolism (NO regulation). Conclusion: Baizhi alleviates migraine through multi-target coordination: reinforcing gut barrier function, enriching anti-inflammatory Lactobacillus, and restoring neurotransmitter/neurovascular homeostasis through 2-AG-mediated CGRP1 inhibition. These findings bridge traditional herbology with modern neuromicrobiology, positioning BZ as a promising gut microbiota-modulating therapy for migraine.
Keywords: Migraine, Angelica dahurica Radix, Gut Microbiota, Metabolomics, Gut-BrainAxis
Received: 19 Jun 2025; Accepted: 22 Sep 2025.
Copyright: © 2025 Lian, Gan, Sun, Zhao, Li, Shen, Xue, Li, Luo, 刘, Feng and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yan Lian, lianyan@cdutcm.edu.cn
Guihua Jiang, jiangguihua@cdutcm.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.